ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1967

Transforming Growth Factor Beta Is a Major Regulator of Micro-RNA Synthesis in Rheumatoid Arthritis Synovial Fibroblasts

Anna Engler1, Emmanuel Karouzakis1, Christoph Kolling2, Renate E. Gay3, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Schulthess Clinic, Zurich, Switzerland, 3Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: fibroblasts and transforming growth factor, MicroRNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Transforming growth factor beta (TGFβ) modulates microRNA (miRNA) biogenesis in a variety of cell types. The expression of miRNAs is deregulated in the synovial fibroblasts from patients with rheumatoid arthritis (RASF). However, the role of TGFβ in the regulation of miRNAs in RASF was not investigated so far. The aim of the current study was to investigate the role of TGFβ in the regulation of miRNAs and in the inflammatory and matrix-destructive properties of RASF. Moreover, the effects of TGFβ on TNFα-induced signaling were analyzed.

Methods

Synovial tissues were obtained from RA patients undergoing joint replacement surgery. RASF (n=6) were stimulated with 10 ng/ml TGFβ, 10 ng/ml TNFα or with TGFβ and TNFα together in cultivation medium supplemented with 5% FCS for 24, 48 or 72 hours. Total RNA was isolated using Qiagen miRNeasy Kit. Global expression of miRNAs was analyzed by human miRNA Array analysis (Card A, Life Technologies) and verified by measurement of single miRNAs using real-time PCR with miRNA-specific TaqMan primers. The levels of interleukins (ILs) and matrix metalloproteinases (MMPs) were detected by Real-time TaqMan and SYBR green PCR.

Results

The global miRNA expression profile was altered by stimulation of RASF with TGFβ after 48h in all patients. The expression of 29 miRNAs was downregulated by 25-70% whereas the levels of 32 miRNAs were upregulated by 50-800%. TGFβ induced changes in several miRNAs that were previously reported to be deregulated in RASF. In particular, the levels of miR-155, miR-221, miR-222 and miR-335 were downregulated, while the expression of miR-18a, miR-22, miR-145 and miR-203 was significantly increased. We then investigated whether TGFβ can modify the effects of TNFα. Stimulation with TNFα alone increased the levels of miR-155 by 8.2-fold±1.2 (p=0.01), while the co-stimulation with TNFα and TGFβ resulted only in 4.3-fold±0.5 (p=0.03) increase in miR-155 levels. Treatment with TNFα decreased the expression of miR-145 by 0.7-fold±0.1 (p=0.03). However, co-stimulation with TNFα and TGFβ reversed this effect completely and increased the levels of miR-145 by 2.0-fold±0.3 (p=0.03). In contrast, TGFβ amplified TNFα-induced reduction in the expression of miR-222 and miR-335. Stimulation with TGFβ or TNFα alone already significantly reduced the expression of these miRNAs and co-stimulation with TGFβ and TNFα together led to a further decrease in the levels of miR-222 (by 0.35-fold±0.05, p=0.03) and miR-335 (by 0.4-fold±0.08, p=0.02). Moreover, TGFβ mitigated the matrix-destructive activities of RASF that were induced by TNFα by strongly decreasing TNFα-induced MMP1 expression (by 16-fold, p=0.04). In contrast TNFα-initiated IL6 production was increased by TGFβ(by 1.7-fold, p=0.03).

Conclusion

In the current study we found that TGFβ modulates the expression of miRNAs involved in the pathogenesis of RA. Moreover, TGFβ influences the inflammatory and matrix-destructive activities of RASF by reduction of TNFα-induced MMP1 expression and by enhancement of TNFα-initiated IL6 production. Thus, TGFβ has dual effects in the regulation of RASF and exhibits pro-inflammatory as well as anti-matrix-destructive properties.


Disclosure:

A. Engler,
None;

E. Karouzakis,
None;

C. Kolling,
None;

R. E. Gay,
None;

S. Gay,
None;

C. Ospelt,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transforming-growth-factor-beta-is-a-major-regulator-of-micro-rna-synthesis-in-rheumatoid-arthritis-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology